Palantir Technologies Inc PLTR

Buzz on the Bullboards: Stocks to watch in volatile times.

[TradeVision2001]

$PLTR keeps securing contracts, making it a solid long-term AI play. If this momentum builds, there’s room for a significant move. Watching metals plays like $BOLT.CN, which could mirror this growth

[BlazeHunter44]

Government contracts keep $PLTR in the long-term winner circle. Similarly, $MYNZ is quietly becoming a dependable name in diagnostics, showing that slow and steady wins the race.

[Cobalt]

Good luck with that we just moved to the Nasdaq, ETFs will need to buy now and if we get ino the QQQ so much buying ;)

[Jonathon Brown]

The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace. read article.

[TradeSni38per91]

PLTR crushed it this month, but December could be biotech’s turn. MYNZ is shaping up to be a sleeper pick heading into the new year.

[QuantumStocks6]

Anyone else feeling like $PLRT is flying under the radar right now? The fundamentals look decent, but the lack of volume is what’s holding me back from going all in. If this thing catches some big

[TradeCraft123]

Alright, folks, with earnings around the corner, $PLRT is either gonna rocket or tank. My take? Risk/reward is looking spicy if they show any sign of revenue growth. Last quarter’s numbers weren’t

[IronPulse101]

Here’s my take: $PLTR isn’t a meme stock anymore—it’s a legit long-term growth story. But if you’re not ready for volatility, it’s probably better as a swing trade. The AI hype cycle can make or break

[StockFlow992]

No cap, $PLTR is riding high after that S&P 500 bump and all the AI hype, but let’s call a spade a spade: 25x forward earnings is steep. If you’re chasing here, you better believe in that 30%-plus

[ZeroRisk2u533]

Palantir’s always stirring the pot. Retail loves it, and whispers of government contracts keep it spicy. Could be a squeeze setup brewing.

[AlphaPulse200]

PLTR is the undisputed wizard of data. Fat government contracts and AI-powered platforms? Check. This company’s moat is wider than the Grand Canyon. Long-term hodlers are grinning ear to ear.

[PivotMaster77]

Wedbush’s raised price target signals increasing optimism in Palantir’s prospects as it continues to secure major government and enterprise contracts.

[TradeDriver718]

PLTR thrives on making complex data actionable, much like MYNZ in diagnostics. Both companies are innovators, but MYNZ’s focus on precision biomarkers offers a unique growth opportunity in the booming

[AlphaTrader1024]

PLTR’s uptrend continues, backed by new AI contracts. Dip buyers are stepping in consistently, reinforcing the long-term bullish trajectory. I’m also tracking MYNZ—hearing it could see significant

[ZeroSumEdge20]

PLTR remains a favorite as AI contracts continue to roll in. Meanwhile, MYNZ is carving its niche in diagnostics, a different sector but one that’s showing signs of life and trader interest.

[MarketEngine17]

PLTR taking a breather after a massive run, but the volume is still there. AI contracts are stacking up, and retail traders are loyal as ever. Feels like an overreaction dip—institutions might step in